吡格列酮+二甲双胍：新药。一种应避免使用的复方制剂。
Pioglitazone + metformin: new drug. A combination product to avoid.
出版信息
Prescrire Int. 2007 Aug;16(90):144.
PMID:17724835
Abstract
More serious adverse effects, and still no tangible proof of efficacy.
摘要
更严重的不良反应，且仍无切实有效的证据。
相似文献
1
Pioglitazone + metformin: new drug. A combination product to avoid.
Prescrire Int. 2007 Aug;16(90):144.
2
Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther. 2006 Jan 30;48(1227):9-11.
3
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. doi: 10.1016/j.numecd.2007.04.003. Epub 2007 Oct 24.
4
Vildagliptin and vildagliptin/metformin: new drug. Same limited efficacy as sitagliptin in type 2 diabetes.
Prescrire Int. 2008 Oct;17(97):188.
5
Pioglitazone: new indication. No glitazones, with or without insulin, for diabetic patients!
Prescrire Int. 2008 Oct;17(97):189.
6
7
[Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med. 2007 Aug 2;149(31-32):52-3.
8
Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2.
9
Pioglitazone and metformin.
Drugs Today (Barc). 2007 Jul;43(7):443-54. doi: 10.1358/dot.2007.43.7.1119722.
10
Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int. 2007 Aug;16(90):144.
Zotero 插件